跳到正文
原文
Biotechnology Innovation Organization· @IAmBiotech · X·· 5 小时前AI 评分15
AI 导读

iNFixion Bioscience 在 #BIO2026 上赢得了 Start-Up Stadium 最高奖。https://Bio.News 与 CEO Herb Sarnoff 讨论了该公司在 1 型神经纤维瘤病方面的工作,这是一种影响 125,000 名美国人的罕见病。阅读更多:https://bio.news/bio-convention/infixion-seeks-nf1-treatment-by-enhancing-what-the-body-is-doing-right/

正文

iNFixion Bioscience won a Start-Up Stadium top prize at #BIO2026. https://Bio.News talks with CEO Herb Sarnoff about the company's work on neurofibromatosis type 1, a rare disease that affects 125,000 Americans. Read more: https://bio.news/bio-convention/infixion-seeks-nf1-treatment-by-enhancing-what-the-body-is-doing-right/

来源:Biotechnology Innovation Organization · x.com